Cited by 717Pancreatic and Hepatic Oncology ResearchCancer Genomics and DiagnosticsPancreatitis Pathology and Treatment

The DOI matches its Crossref record; 185 of the 185 references it cites were found in a registry or an index.

Pancreatic Cancer

Open access

Maitra, Anirban, Hruban, Ralph H.·2008·Annual Review of Pathology: Mechanisms of Disease

DOI 10.1146/annurev.pathmechdis.3.121806.154305PMC PMC2666336

Open this paper in CoChat — free account

Abstract

The past two decades have witnessed an explosion in our understanding of pancreatic cancer, and it is now clear that pancreatic cancer is a disease of inherited (germ-line) and somatic gene mutations. The genes mutated in pancreatic cancer include KRAS2, p16/CDKN2A, TP53, and SMAD4/DPC4, and these are accompanied by a substantial compendium of genomic and transcriptomic alterations that facilitate cell cycle deregulation, cell survival, invasion, and metastases. Pancreatic cancers do not arise de novo, and three distinct precursor lesions have been identified. Experimental models of pancreatic cancer have been developed in genetically engineered mice, which recapitulate the multistep progression of the cognate human disease. Although the putative cell of origin for pancreatic cancer remains elusive, minor populations of cells with stem-like properties have been identified that appear responsible for tumor initiation, metastases, and resistance of pancreatic cancer to conventional therapies.

Integrity signals

Registry

Crossref · 10.1146/annurev.pathmechdis.3.121806.154305

Cites

185 of 185 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Retracted: Notch‐1 down‐regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells
Wang, Z., Zhang, Y., Banerjee, S., Li, Y., & Sarkar, F. H. (2006) · Cancer · doi:10.1002/cncr.21904 · Cited by 263
Retracted
Prospective identification of tumorigenic breast cancer cells
Al‐Hajj, M., Wicha, M. S., Benito‐Hernández, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,579
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,637
1969 Cancer Facts and Figures
(1968) · American Association of Industrial Nurses Journal · doi:10.1177/216507996801601208 · Cited by 8,811
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
Bonnet, D. A., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 7,197
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,517
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
Burris, H. A., Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M., Cripps, M. C., Portenoy, R. K., Storniolo, A. M., Tarassoff, P. G., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2403 · Cited by 5,895
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783

Show all 185 references

Research works printed but not linked: 24

10.1001/jama.1995.03520440059037 · DOI
Goggins M, 1996, Cancer Res., 56, 5360
de vos tot Nederveen Cappel WH, 2003, Clin. Cancer Res., 9, 3598
Goggins M, 1998, Am. J. Pathol., 152, 1501
Hruban RH, 2006, Tumors of the Pancreas
Iacobuzio-Donahue CA, 2003, Cancer Res., 63, 8614
Argani P, 2001, Cancer Res., 61, 4320
Argani P, 2001, Clin. Cancer Res., 7, 3862
Moskaluk CA, 1997, Cancer Res., 57, 2140
Altomare DA, 2003, J. Cell Biochem., 88, 470
Schutte M, 1997, Cancer Res., 57, 3126
Redston MS, 1994, Cancer Res., 54, 3025
Wilentz RE, 2000, Cancer Res., 60, 2002
Schutte M, 1996, Cancer Res., 56, 2527
Goggins M, 1998, Cancer Res., 58, 5329
Sato N, 2003, Cancer Res., 63, 4158
Ryu B, 2002, Cancer Res., 62, 819
Deramaudt T, 2005, Biochim. Biophys. Acta, 1756, 97
Brembeck FH, 2003, Cancer Res., 63, 2005
Ryu B, 2002, Cancer Res., 62, 819
Zhou W, 1998, Cancer Epidemiol. Biomark. Prev., 7, 109
Yamada T, 1998, Clin. Cancer Res., 4, 1527
Yamamoto H, 2001, Cancer Res., 61, 3139
van der Heijden MS, 2003, Cancer Res., 63, 2585

Sorted by citations

Items 301–400 of 717

Molecular Subtyping of Pancreatic Cancer: Translating Genomics and Transcriptomics into the Clinic
Du, Y., Zhao, B., Liu, Z., Ren, X., Zhao, W., Li, Z., You, L., & Zhao, Y. (2017) · Journal of Cancer · doi:10.7150/jca.17622 · Cited by 32
Targeting Pancreatic Cancer Cell Plasticity: The Latest in Therapeutics
Smigiel, J. M., Parameswaran, N., & Jackson, M. W. (2018) · Cancers · doi:10.3390/cancers10010014 · Cited by 31
TGIF1 functions as a tumor suppressor in pancreatic ductal adenocarcinoma
Parajuli, P., Singh, P., Wang, Z., Li, L., Eragamreddi, S., Ozkan, S., Ferrigno, O., Prunier, C., Razzaque, M. S., Xu, K., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2018101067 · Cited by 30
Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice
Selvanesan, B. C., Meena, K., Beck, A. P., Meheus, L., Lara, O., Rooman, I., & Gravekamp, C. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001250 · Cited by 31
Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling
Xue, A., Xue, M., Jackson, C., & Smith, R. C. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.03.004 · Cited by 31
Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model
Hidalgo‐Sastre, A., Brodylo, R. L., Lubeseder–Martellato, C., Sipos, B., Steiger, K., Lee, M., von Figura, G., Grünwald, B. T., Zhong, S., Trajkovic‐Arsic, M., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.07.025 · Cited by 31
Inactivation ofBrca2cooperates withTrp53R172Hto induce invasive pancreatic ductal adenocarcinomas in mice
Feldmann, G., Karikari, C. A., Molin, M. D., Duringer, S., Volkmann, P., Bartsch, D. K., Bisht, S., Koorstra, J.-B. M., Brossart, P., Maitra, A., et al. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.11.15534 · Cited by 30
Self-citation
ZIP4 confers resistance to zinc deficiency-induced apoptosis in pancreatic cancer
Cui, X., Zhang, Y., Yang, J., Sun, X., Hagan, J. P., Guha, S., & Li, M. (2014) · Cell Cycle · doi:10.4161/cc.28111 · Cited by 30
Organoid-based ex vivo reconstitution of Kras-driven pancreatic ductal carcinogenesis
Matsuura, T., Maru, Y., Izumiya, M., Hoshi, D., Kato, S., Ochiai, M., Hori, M., Yamamoto, S., Tatsuno, K., Imai, T., et al. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz122 · Cited by 30
Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas
Paini, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.10008 · Cited by 31
Ran GTPase protein promotes human pancreatic cancer proliferation by deregulating the expression of Survivin and cell cycle proteins
Deng, L., Lu, Y., Zhao, X., Sun, Y., Shi, Y., Fan, H., Liu, C., Zhou, J., Nie, Y., Wu, K., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.09.079 · Cited by 29
Cdc7 is a potent anti-cancer target in pancreatic cancer due to abrogation of the DNA origin activation checkpoint
Huggett, M. T., Tudzarova, S., Proctor, I., Loddo, M., Keane, M. G., Stoeber, K., Williams, G. H., & Pereira, S. P. (2016) · Oncotarget · doi:10.18632/oncotarget.7611 · Cited by 29
Good and Bad Stroma in Pancreatic Cancer: Relevance of Functional States of Cancer-Associated Fibroblasts
Ando, R., Sakai, A., Iida, T., Kataoka, K., Mizutani, Y., & Enomoto, A. (2022) · Cancers · doi:10.3390/cancers14143315 · Cited by 31
A TRANSCRIPTOME ANALYSIS BY LASSO PENALIZED COX REGRESSION FOR PANCREATIC CANCER SURVIVAL
Wu, T. T., Gong, H., & Clarke, E. M. (2011) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720011005744 · Cited by 29
Development and Histopathological Characterization of Tumorgraft Models of Pancreatic Ductal Adenocarcinoma
Garcia, P. L., Christein, J. D., Arnoletti, J. P., Heslin, M. J., Gamblin, T. L., Richardson, J. H., Bjornsti, M., & Yoon, K. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078183 · Cited by 29
Synergistic interactions between sorafenib and everolimus in pancreatic cancer xenografts in mice
Pawaskar, D. K., Straubinger, R. M., Fetterly, G. J., Hylander, B. H., Repasky, E. A., Ma, W. W., & Jusko, W. J. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2117-x · Cited by 29
Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer
Birnbaum, D. J., Bertucci, F., Finetti, P., Birnbaum, D., & Mamessier, É. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.02.001 · Cited by 29
Ultrasound-induced Cavitation enhances the efficacy of Chemotherapy in a 3D Model of Pancreatic Ductal Adenocarcinoma with its microenvironment
Leenhardt, R., Camus, M., Mestas, J., Jeljeli, M. M., Ali, E. A., Chouzenoux, S., Bordaçahar, B., Nicco, C., Batteux, F., Lafon, C., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-55388-0 · Cited by 30
The trilogy of P21 activated kinase, autophagy and immune evasion in pancreatic ductal adenocarcinoma
Ma, Y., Nikfarjam, M., & He, H. Z. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215868 · Cited by 28
Emerging role of pancreatic stellate cell-derived extracellular vesicles in pancreatic cancer
Sarkar, R., Xu, Z., Perera, C. J., & Apte, M. V. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.05.007 · Cited by 28
In vitromodels of pancreatic cancer for translational oncology research
Feldmann, G., Rauenzahn, S. L., & Maitra, A. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440902821657 · Cited by 28
Self-citation
Deep sequencing and in silico analyses identify MYB-regulated gene networks and signaling pathways in pancreatic cancer
Azim, S., Zubair, H., Srivastava, S. K., Bhardwaj, A., Zubair, A., Ahmad, A., Singh, S., Khushman, M. M., & Singh, A. P. (2016) · Scientific Reports · doi:10.1038/srep28446 · Cited by 28
Antagonizing CD105 enhances radiation sensitivity in prostate cancer
Madhav, A., Andres, A. M., Duong, F. L., Mishra, R., Haldar, S., Liu, Z., Angara, B., Gottlieb, R. A., Zumsteg, Z. S., & Bhowmick, N. A. (2018) · Oncogene · doi:10.1038/s41388-018-0278-0 · Cited by 28
Depletion of the lncRNA RP11-567G11.1 inhibits pancreatic cancer progression
Huang, R., Nie, W., Yao, K., & Chou, J. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108685 · Cited by 28
Superoxide Dismutases in Pancreatic Cancer
Wilkes, J. G., Alexander, M. S., & Cullen, J. J. (2017) · Antioxidants · doi:10.3390/antiox6030066 · Cited by 27
Suppression of Gingival NK Cells in Precancerous and Cancerous Stages of Pancreatic Cancer in KC and BLT-Humanized Mice
Kaur, K., Chang, H.-H., Cook, J., Eibl, G., & Jewett, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01606 · Cited by 27
Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma
Birnbaum, D. J., Begg, S. K. S., Finetti, P., Vanderburg, C. R., Kulkarni, A. S., Neyaz, A., Hank, T. P., Tai, E. C., Deshpande, V., Bertucci, F., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1039 · Cited by 27
Molecular alterations in pancreatic tumors
Visani, M., Acquaviva, G., Leo, A. D., Sanza, V., Merlo, L., Maloberti, T., Brandes, A. A., Franceschi, E., Battista, M. D., Masetti, M., et al. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i21.2710 · Cited by 29
Zebrafish imaging reveals TP53 mutation switching oncogene-induced senescence from suppressor to driver in primary tumorigenesis
Haraoka, Y., Akieda, Y., Nagai, Y., Mogi, C., & Ishitani, T. (2022) · Nature Communications · doi:10.1038/s41467-022-29061-6 · Cited by 28
Dynamic Interplay between Structural Variations and 3D Genome Organization in Pancreatic Cancer
Du, Y., Gu, Z., Li, Z., Yuan, Z., Zhao, Y., Zheng, X., Bo, X., Chen, H., & Wang, C. (2022) · Advanced Science · doi:10.1002/advs.202200818 · Cited by 28
Molecular Biologic Approach to the Diagnosis of Pancreatic Carcinoma Using Specimens Obtained by EUS-Guided Fine Needle Aspiration
Kato, K., Kamada, H., Fujimori, T., Aritomo, Y., Ono, M., & Masaki, T. (2012) · Gastroenterology Research and Practice · doi:10.1155/2012/243524 · Cited by 27
Ancistroyafungines A-D, 5,8′- and 5,1′-coupled naphthylisoquinoline alkaloids from a Congolese Ancistrocladus species, with antiausterity activities against human PANC-1 pancreatic cancer cells
Muyisa, S., Lombe, B. K., Feineis, D., Dibwe, D. F., Maharaj, V. J., Awale, S., & Bringmann, G. (2018) · Fitoterapia · doi:10.1016/j.fitote.2018.07.017 · Cited by 27
Aberrant expression of PDZ-binding kinase/T-LAK cell-originated protein kinase modulates the invasive ability of human pancreatic cancer cells via the stabilization of oncoprotein c-MYC
Hinzman, C. P., Aljehane, L., Brown-Clay, J. D., Kallakury, B., Sonahara, F., Goel, A., Trevino, J. G., & Banerjee, P. P. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy114 · Cited by 28
Advances in tumor subclone formation and mechanisms of growth and invasion
Zhang, Y., & Wang, W. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06486-3 · Cited by 27
Tumour Suppressor Mechanisms in the Control of Chromosome Stability: Insights from BRCA2
Venkitaraman, A. R. (2014) · Molecules and Cells · doi:10.14348/molcells.2014.2346 · Cited by 26
Genetic GIScience: Toward a Place-Based Synthesis of the Genome, Exposome, and Behavome
Jacquez, G. M., Sabel, C. E., & Chen, S. (2015) · Annals of the Association of American Geographers · doi:10.1080/00045608.2015.1018777 · Cited by 26
Characterization of Pancreatic Cancer Cell Thermal Response to Heat Ablation or Cryoablation
Baumann, K. W., Baust, J. M., Snyder, K. K., Baust, J. G., & Buskirk, R. G. V. (2016) · Technology in Cancer Research & Treatment · doi:10.1177/1533034616655658 · Cited by 26
Pancreatic Cancer Gene Therapy Delivered by Nanoparticles
Kurtanich, T. R., Roos, N., Wang, G., Yang, J., Wang, A., & Chung, E. J. (2018) · SLAS TECHNOLOGY · doi:10.1177/2472630318811108 · Cited by 26
Highlights on the Role of KRAS Mutations in Reshaping the Microenvironment of Pancreatic Adenocarcinoma
Hafezi, S., Saber-Ayad, M. M., & Abdel‐Rahman, W. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910219 · Cited by 28
Lysyl oxidase propeptide sensitizes pancreatic and breast cancer cells to doxorubicin‐induced apoptosis
Min, C., Zhao, Y., Romagnoli, M., Trackman, P. C., Sonenshein, G. E., & Kirsch, K. H. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22828 · Cited by 26
The zinc-finger protein KCMF1 is overexpressed during pancreatic cancer development and downregulation of KCMF1 inhibits pancreatic cancer development in mice
Beilke, S., Oswald, F., Genze, F., Wirth, T. C., Adler, G., & Wagner, M. (2010) · Oncogene · doi:10.1038/onc.2010.156 · Cited by 26
Limitations in Improving Detection of Pancreatic Adenocarcinoma
Zerón, H. M., Flores, J. R. G., & Romero, M. L. (2009) · Future Oncology · doi:10.2217/fon.09.32 · Cited by 25
Identification of KIAA1199 as a Biomarker for Pancreatic Intraepithelial Neoplasia
Suh, H. N., Jun, S., Oh, A.-Y., Srivastava, M., Lee, S., Taniguchi, C. M., Zhang, S., Lee, W. S., Chen, J., Park, B.-J., et al. (2016) · Scientific Reports · doi:10.1038/srep38273 · Cited by 26
The association between glutathione S-transferase gene polymorphisms and pancreatic cancer in a central European Slavonic population
Vrána, D., Pikhart, H., Mohelníková-Duchoňová, B., Holcátová, I., Strnad, R., Slámová, A., Schejbalová, M., Ryska, M., Susova, S., & Souček, P. (2009) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2009.09.005 · Cited by 25
An oncogenic KRAS transcription program activates the RHOGEF ARHGEF2 to mediate transformed phenotypes in pancreatic cancer
Kent, O. A., Sandí, M. J., Burston, H. E., Brown, K. R., & Rottapel, R. K. (2016) · Oncotarget · doi:10.18632/oncotarget.13152 · Cited by 25
A systematic study of novel drug delivery mechanisms and treatment strategies for pancreatic cancer
Hani, U., Osmani, R. A. M., Siddiqua, A., Wahab, S., Batool, S., Ather, H., Sheraba, N. S., & Alqahtani, A. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102539 · Cited by 25
The TGF-β superfamily as potential therapeutic targets in pancreatic cancer
Tindall, R. R., Bailey, J. M., Cao, Y., & Ko, T. C. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1362247 · Cited by 26
Arrested development and the great escape – The role of cellular senescence in pancreatic cancer
Moir, J. A. G., White, S. A., & Mann, J. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.10.018 · Cited by 26
Variant Profiling of Candidate Genes in Pancreatic Ductal Adenocarcinoma
Huang, J., Löhr, M. J., NILSSON, M. H. L., Segersvärd, R., Matsson, H., Verbeke, C. S., Heuchel, R. L., Kere, J., Iafrate, A. J., Zheng, Z., et al. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.238543 · Cited by 27
The ‘SPARC’ of life: Analysis of the role of osteonectin/SPARC in pancreatic cancer (Review)
ROSSI, M. K., Gnanamony, M., & Gondi, C. S. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3417 · Cited by 25
Epithelial to Stromal Re-Distribution of Primary Cilia during Pancreatic Carcinogenesis
Schimmack, S. J., Kneller, S., Dadabaeva, N., Bergmann, F., Taylor, A., Hackert, T., Werner, J., & Strobel, O. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164231 · Cited by 26
The Rho/MRTF pathway inhibitor CCG-222740 reduces stellate cell activation and modulates immune cell populations in KrasG12D; Pdx1-Cre (KC) mice
Leal, A. S., Misek, S. A., Lisabeth, E. M., Neubig, R. R., & Liby, K. T. (2019) · Scientific Reports · doi:10.1038/s41598-019-43430-0 · Cited by 25
Notch1 Is Not Required for Acinar-to-Ductal Metaplasia in a Model of Kras-Induced Pancreatic Ductal Adenocarcinoma
Avila, J. L., Troutman, S. A., Durham, A. C., & Kissil, J. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052133 · Cited by 25
Pathway-gene identification for pancreatic cancer survival via doubly regularized Cox regression
Gong, H., Wu, T. T., & Clarke, E. M. (2014) · BMC Systems Biology · doi:10.1186/1752-0509-8-s1-s3 · Cited by 24
Deguelin inhibits proliferation and migration of human pancreatic cancer cells in vitro targeting hedgehog pathway
Zheng, W. L., Lu, S., Cai, H., Kang, M., Qin, W., Li, C. R., & Wu, Y. (2016) · Oncology Letters · doi:10.3892/ol.2016.4928 · Cited by 24
Pancreatic ductal adenocarcinoma: tumor microenvironment and problems in the development of novel therapeutic strategies
Kuznetsova, A. V., Попова, О. П., Panchenkov, D. N., Dyuzheva, Т. G., & Aa, I. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00886-1 · Cited by 24
APC haploinsufficiency coupled with p53 loss sufficiently induces mucinous cystic neoplasms and invasive pancreatic carcinoma in mice
Kuo, T.-L., Weng, C.-C., Kuo, K.-K., Chen, C.-Y., Dc, W., Hung, W., & Cheng, K.-H. (2015) · Oncogene · doi:10.1038/onc.2015.284 · Cited by 24
Oncotropic H-1 parvovirus infection degrades HIF-1α protein in human pancreatic cancer cells independently of VHL and RACK1
Cho, I.-R., Kaowinn, S., Moon, J., SOH, J., Kang, H. Y., Jung, C., Oh, S., Song, H., Koh, S. S., & CHUNG, Y.-H. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2922 · Cited by 24
Correlation of 18F-Fluorodeoxyglucose Positron Emission Tomography Parameters with Patterns of Disease Progression in Locally Advanced Pancreatic Cancer after Definitive Chemoradiotherapy
Wilson, J. M., Mukherjee, S., Brunner, T. B., Partridge, M., & Hawkins, M. (2017) · Clinical Oncology · doi:10.1016/j.clon.2017.01.038 · Cited by 24
Histone Deacetylase Inhibition Restores Expression of Hypoxia-Inducible Protein NDRG1 in Pancreatic Cancer
Tiffon, C. (2018) · Pancreas · doi:10.1097/mpa.0000000000000982 · Cited by 24
A novel hotspot and rare somatic mutation p.A138V, at TP53 is associated with poor survival of pancreatic ductal and periampullary adenocarcinoma patients
Saha, G., Singh, R., Mandal, A., Das, S. K., Chattopadhyay, E., Panja, P., Roy, P., Sarkar, N. D., Gulati, S., Ghatak, S., et al. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00183-1 · Cited by 23
THBS2/CA19-9 Detecting Pancreatic Ductal Adenocarcinoma at Diagnosis Underperforms in Prediagnostic Detection: Implications for Biomarker Advancement
Udgata, S., Takenaka, N., Bamlet, W. R., Oberg, A. L., Yee, S. S., Carpenter, E. L., Herman, D. S., Kim, J., Petersen, G. M., & Zaret, K. S. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0403 · Cited by 27
Direct Endoplasmic Reticulum Targeting by the Selective Alkylphospholipid Analog and Antitumor Ether Lipid Edelfosine as a Therapeutic Approach in Pancreatic Cancer
Mollinedo, F., & Gajate, C. (2021) · Cancers · doi:10.3390/cancers13164173 · Cited by 25
Personalising pancreas cancer treatment: When tissue is the issue
Sjoquist, K. M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i24.7849 · Cited by 24
ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesisPreprint
Wang, L., Yang, H., Zamperone, A., Diolaiti, D., Palmbos, P. L., Abel, E. V., Purohit, V., Dolgalev, I., Rhim, A. D., Ljungman, M. E., et al. (2019) · Genes & Development · doi:10.1101/gad.323303.118 · Cited by 24
Advancing pancreatic cancer research and therapeutics: the transformative role of organoid technology
Xu, J., Pham, M. D., Corbo, V., Ponz‐Sarvisé, M., Oni, T. E., Öhlund, D., & Hwang, C. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01378-w · Cited by 28
Tissue acquisition and pancreatic masses: Which needle and which acquisition technique should be used?
Mangiavillano, B., Sosa-Valencia, L., Deprez, P. H., Eisendrath, P., Robles‐Medranda, C., Eusebi, L. H., Leo, M. D., Auriemma, F., Bianchetti, M. G., Anderloni, A. A., et al. (2020) · Endoscopy International Open · doi:10.1055/a-1221-4578 · Cited by 23
Circulating tumour DNA: a challenging innovation to develop “precision onco-surgery” in pancreatic adenocarcinoma
Pietrasz, D., Sereni, E., Lancellotti, F., Pea, A., Luchini, C., Innamorati, G., Salvia, R., & Bassi, C. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01745-2 · Cited by 25
PCDH1 promotes progression of pancreatic ductal adenocarcinoma via activation of NF-κB signalling by interacting with KPNB1
Ye, Z., Yang, Y., Wei, Y., Li, L., Wang, X., & Zhang, J. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05087-y · Cited by 23
IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation
Cao, P., Wu, Y., Sun, D., Zhang, W., Qiu, J., Tang, Z., Xue, X., & Qin, L. (2022) · Cancer Medicine · doi:10.1002/cam4.5096 · Cited by 22
A new goniothalamin N-acylated aza-derivative strongly downregulates mediators of signaling transduction associated with pancreatic cancer aggressiveness
Barcelos, R. C., Pelizzaro‐Rocha, K. J., Pastre, J. C., Dias, M. P., Ferreira‐Halder, C. V., & Pilli, R. A. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.085 · Cited by 23
The need for effective pancreatic cancer detection and management: a biomarker-based strategy
Crawley, A. S., & O’Kennedy, R. J. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1083862 · Cited by 22
Recent Advances and Prospects for Multimodality Therapy in Pancreatic Cancer
Chadha, A. S., Khoo, A., Aliru, M. L., Arora, H. K., Gunther, J. R., & Krishnan, S. (2016) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2016.05.002 · Cited by 23
Identification of Serum miRNA Signature and Establishment of a Nomogram for Risk Stratification in Patients With Pancreatic Ductal Adenocarcinoma
Kandimalla, R., Shimura, T., Mallik, S., Sonohara, F., Tsai, S., Evans, D. B., Kim, S. C., Baba, H., Kodera, Y., Hoff, D. D. V., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003945 · Cited by 23
Inhibition of hTERT/telomerase contributes to the antitumor activity of pristimerin in pancreatic ductal adenocarcinoma cells
Deeb, D., Gao, X., Liu, Y., Pindolia, K. R., & Gautam, S. C. (2015) · Oncology Reports · doi:10.3892/or.2015.3989 · Cited by 23
Metabolic Profiling of Early and Late Recurrent Pancreatic Ductal Adenocarcinoma Using Patient-Derived Organoid Cultures
Braun, L. M., Lagies, S., Klar, R. F. U., Hussung, S., Fritsch, R., Kammerer, B., & Wittel, U. A. (2020) · Cancers · doi:10.3390/cancers12061440 · Cited by 22
Ablative Radiotherapy Reprograms the Tumor Microenvironment of a Pancreatic Tumor in Favoring the Immune Checkpoint Blockade Therapy
Lee, Y.-H., Yu, C., Yang, Y., Hong, J., & Chiang, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042091 · Cited by 22
SYT8 promotes pancreatic cancer progression via the TNNI2/ERRα/SIRT1 signaling pathway
Fu, Z., Liang, X., Shi, L., Tang, L., Chen, D., Liu, A., & Shao, C. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00779-4 · Cited by 22
Pancreatic Cancer and Diabetes
Morrison, M. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5441-0_18 · Cited by 21
PHLPP negatively regulates cell motility through inhibition of Akt activity and integrin expression in pancreatic cancer cells
Smith, A., Wen, Y., Stevens, P. D., Liu, J., Wang, C., & Gao, T. (2016) · Oncotarget · doi:10.18632/oncotarget.6848 · Cited by 23
Retracted : CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial‐mesenchymal transition via the Wnt/β‐catenin signaling pathway
He, Y., Xiao, Y., Wei, L., Zhang, J., & Peng, C. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26643 · Cited by 22
Retracted
The inhibition of cell proliferation and induction of apoptosis in pancreatic ductal adenocarcinoma cells by verrucarin A, a macrocyclic trichothecene, is associated with the inhibition of Akt/NF-κB/mTOR prosurvival signaling
Deeb, D., Gao, X., Liu, Y., Zhang, Y., Shaw, J., Valeriote, F. A., & Gautam, S. C. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3587 · Cited by 21
A New Strategy to Control and Eradicate “Undruggable” Oncogenic K-RAS-Driven Pancreatic Cancer: Molecular Insights and Core Principles Learned from Developmental and Evolutionary Biology
Sciver, R. E. V., Lee, M., Lee, C. G. L., Lafever, A., Svyatova, E. A., Kanda, K., Collier, A. L., van Reesema, L. L. S., Tang-Tan, A. M., Zheleva, V. P., et al. (2018) · Cancers · doi:10.3390/cancers10050142 · Cited by 21
Anticancer effects on human pancreatic cancer cells of triterpenoids, polysaccharides and 1,3-β- d -glucan derived from the fruiting body of Antrodia camphorata
Lee, C., Wu, C., Hsieh, S., Lee, C.-L., Chang, Y.-P., Chang, C.-C., Wang, Y., & Wang, J. (2014) · Food & Function · doi:10.1039/c4fo00720d · Cited by 21
Predicting novel salivary biomarkers for the detection of pancreatic cancer using biological feature-based classification
Liu, H.-J., Guo, Y., & Li, D.-J. (2016) · Pathology - Research and Practice · doi:10.1016/j.prp.2016.09.017 · Cited by 21
Animal models for modeling pancreatic cancer and novel drug discovery
Bisht, S., & Feldmann, G. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1566319 · Cited by 21
Targeted radionuclide therapies for pancreatic cancer
Shah, M., Silva, R. D., Gravekamp, C., Libutti, S. K., Abraham, T., & Dadachova, E. (2015) · Cancer Gene Therapy · doi:10.1038/cgt.2015.32 · Cited by 21
PAUF promotes adhesiveness of pancreatic cancer cells by modulating focal adhesion kinase
Lee, Y., Kim, S. J., Min, H. J., Jo, J. Y., Park, E. H., & Koh, S. S. (2011) · Experimental & Molecular Medicine · doi:10.3858/emm.2011.43.5.030 · Cited by 21
Molecular pathway of pancreatic cancer‐associated neuropathic pain
Giri, S. S., Tripathi, A. S., Erkekoğlu, P., & Zaki, M. E. A. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23638 · Cited by 21
Diagnostic Management of Pancreatic Cancer
Dabizzi, E., Assef, M. S., & Raimondo, M. (2011) · Cancers · doi:10.3390/cancers3010494 · Cited by 20
Two Novel Nomograms Predicting the Risk and Prognosis of Pancreatic Cancer Patients With Lung Metastases: A Population-Based Study
Zhang, W., Ji, L., Zhong, X., Zhu, S., Zhang, Y., Ge, M., Kang, Y., & Bi, Q. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.884349 · Cited by 20
Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer
Mustafa, M., Abbas, K., Alam, M., Habib, S., Zulfareen, Hasan, G. M., Islam, S., Shamsi, A., & Hassan, M. I. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1427802 · Cited by 25
CDDO-Me inhibits tumor growth and prevents recurrence of pancreatic ductal adenocarcinoma
Gao, X., Deeb, D., Liu, Y., Liu, P., Zhang, Y., Shaw, J., & Gautam, S. C. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3212 · Cited by 20
Coordinate Loss of Fragile Gene Expression in Pancreatobiliary Cancers: Correlations Among Markers and Clinical Features
Bloomston, M., Kneile, J., Butterfield, M., Dillhoff, M. E., Muscarella, P., Ellison, E. C., Melvin, W. S., Croce, C. M., Pichiorri, F., Huebner, K., et al. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0507-4 · Cited by 20
Snail Cooperates with KrasG12D In Vivo to Increase Stem Cell Factor and Enhance Mast Cell Infiltration
Knab, L. M., Ebine, K., Chow, C. R., Raza, S. S., Sahai, V., Patel, A. P., Kumar, K., Bentrem, D. J., Grippo, P. J., & Munshi, H. G. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0111 · Cited by 20
The Cancer Genomics Resource List 2014
Zutter, M. M., Bloom, K. J., Liang Cheng, C., Hagemann, I. S., Kaufman, J. H., Krasinskas, A. M., Lazar, A. J., Leonard, D. G. B., Lindeman, N. I., Moyer, A. M., et al. (2014) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2014-0330-cp · Cited by 20
Suppression of Lefty expression in induced pluripotent cancer cells
Saito, A. M., Ochiai, H., Okada, S., Miyata, N., & Azuma, T. (2013) · The FASEB Journal · doi:10.1096/fj.12-221432 · Cited by 20
CDDO-Me: A Novel Synthetic Triterpenoid for the Treatment of Pancreatic Cancer
Deeb, D., Gao, X., Arbab, A. S., Barton, K. N., Dulchavsky, S. A., & Gautam, S. C. (2010) · Cancers · doi:10.3390/cancers2041779 · Cited by 21
Pancreatic adenocarcinoma up-regulated factor expression is associated with disease-specific survival in cervical cancer patients
Choi, C. H., Chung, J., Park, H.-S., Jun, M., Lee, Y.-Y., Kim, B.-G., & Hewitt, S. M. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.02.016 · Cited by 20
Novel strategies for managing pancreatic cancer
Loc, W. S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i40.14717 · Cited by 23

Authors: Maitra, A., & Hruban, R. H.
Affiliations: Johns Hopkins University (US)
ORCID: Maitra, Anirban
Hruban, Ralph H.
Venue: Annual Review of Pathology: Mechanisms of Disease
Publisher: Annual Reviews
Published: 2008-02-01
Volume: 3
Issue: 1
Pages: 157-188
ISSN: 1553-4006 (ISSN-L)
1553-4014
DOI: 10.1146/annurev.pathmechdis.3.121806.154305
PMC: PMC2666336
OpenAlex: W4211122150
Cited by: 707
References: 185
Citations by year: 2026: 16 · 2025: 10 · 2024: 31 · 2023: 29 · 2022: 55 · 2021: 46 · 2020: 46 · 2019: 39 · 2018: 43 · 2017: 42 · 2016: 41 · 2015: 53 · 2014: 59 · 2013: 48 · 2012: 32
FWCI: 3.60
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Annual Review of Pathology Mechanisms of Disease (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (R01CA113669, P50CA062924)
Topics: Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
Keywords: pancreatic cancer, germline mutations, somatic mutations, KRAS2, CDKN2A, TP53, genetic alterations, transcriptomic alterations, cell cycle dysregulation, metastasis, precursor lesions, genetically engineered mouse models, tumor progression, cancer stem cells, treatment resistance
MeSH terms: Animals, Disease Models, Animal, Humans, Pancreatic Neoplasms, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pancreatic Cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks